Výsledky vyhledávání - "Carole Belaïdi"

Sustained efficacy of agomelatine 10 mg, 25 mg, and 25–50 mg on depressive symptoms and functional outcomes in patients with major depressive disorder. A placebo-controlled study over 6 months

Autor: Carole Belaïdi, Christian de Bodinat, Alla Avedisova, F. Picarel-Blanchot, Sidney H. Kennedy

Publikováno v: European Neuropsychopharmacology. 26:378-389

This randomized placebo-controlled "dose relation study" was conducted in patients who met criteria for major depressive disorder, to evaluate the efficacy and safety of agomelatine during 24 weeks at 3 doses (i) low fixed dosage (10 mg/day, n=100 pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6519d190dd30a94991916e6fe68c9a0
https://doi.org/10.1016/j.euroneuro.2015.09.006

Zobrazit plný text záznamu

Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial

Autor: Emmanuelle Corruble, Guy M. Goodwin, Christian de Bodinat, Carole Belaïdi

Publikováno v: The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 16(10)

In the present randomized, controlled, double-blind trial (12 wk treatment plus double-blind extension for 12 wk), 25–50 mg/d agomelatine (n = 164) and 10–20 mg/d escitalopram (n = 160) were compared for short- and long-term efficacy, subjective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0c9fccf9c312fe49bf9c8041590a48
http://ora.ox.ac.uk/objects/uuid:1b17cc76-7059-42c0-8471-8072894a1a7f

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání